Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | |
|---|---|---|---|---|---|
| 1 | 2 | ||||
| Chest pain | Chest pain | x | x | ||
| Corneal opacity | Corneal opacity | x | x | ||
| Dyspnoea | Dyspnoea | x | x | ||
| Hyperaemia | Hyperaemia | x | x | ||
| Hypersensitivity | Hypersensitivity | x | x | ||
| Paraesthesia | Paraesthesia | x | |||
| Eye pain | Eye pain | x | x | ||
| Eye irritation | Eye irritation | x | x | ||
| Lacrimation increased | Lacrimation | x | x | ||
| Sensation of foreign body | Sensation of foreign body | x | x | ||
| Eye oedema | Eye oedema | x | x | ||
| Ocular discomfort | Ocular discomfort | x | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |